Joyce A. Sutcliffe
Plus aucun poste en cours
Profil
Joyce A.
Sutcliffe worked as a Principal at Abbott Laboratories and Pfizer Inc. She was also a Vice President-Research at BlueWillow Biologics, Inc. and a Senior Vice President-Biology at Tetraphase Pharmaceuticals, Inc. Her former position was Chief Research Scientist & Vice President-Biology at Melinta Subsidiary Corp.
She received her undergraduate and doctorate degrees from the University of Florida.
Anciens postes connus de Joyce A. Sutcliffe
| Sociétés | Poste | Fin |
|---|---|---|
| TETRAPHASE PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| ABBOTT LABORATORIES | Corporate Officer/Principal | - |
Melinta Subsidiary Corp.
 Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Directeur Technique/Scientifique/R&D | - |
| PFIZER, INC. | Corporate Officer/Principal | - |
BlueWillow Biologics, Inc.
 BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | Corporate Officer/Principal | - |
Formation de Joyce A. Sutcliffe
| University of Florida | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| ABBOTT LABORATORIES | Health Technology |
| Entreprise privées | 3 |
|---|---|
BlueWillow Biologics, Inc.
BlueWillow Biologics, Inc. BiotechnologyHealth Technology BlueWillow Biologics, Inc. develops biopharmaceutical products. It offers vaccines targeting respiratory, sexually transmitted, and intranasal immunotherapy for food and respiratory allergies. The company was founded by James R. Baker Jr. and is headquartered in Ann Arbor, MI. | Health Technology |
Melinta Subsidiary Corp.
Melinta Subsidiary Corp. Pharmaceuticals: MajorHealth Technology Melinta Subsidiary Corp. develops and markets pharmaceutical products for the treatment of life-threatening infections. It also develops novel classes of antibiotics to treat the multi- and extremely-drug-resistant pathogens for which there are few to no options, known collectively as ESKAPE pathogens. The company was founded by John N. Abelson, Harry F. Noller, Susan Froshauer, Harry H. Penner, Jr., William L. Jorgensen, Thomas A. Steitz, and Peter Moore in October 2000 and is headquartered in New Haven, CT. | Health Technology |
Tetraphase Pharmaceuticals, Inc.
 Tetraphase Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tetraphase Pharmaceuticals, Inc. is engaged in the development and production of novel tetracyclines for serious and life-threatening bacterial infections. It also develops eravacycline, a synthetic fluorocycline, as an intravenous and oral antibiotic for use as a first-line empiric monotherapy for the treatment of resistant and multi-drug-resistant infections. The company was founded on July 7, 2006 and is headquartered in Waltham, MA. | Health Technology |
